29.9 C
New York
Saturday, June 13, 2026

Tag: food

newssourceFORcompanyinformationcontent1marketreleases

Amaze Showcases the Future of Creator-Led Businesses at VidCon 2026

Company brings Amaze Commerce and The Food Channel to VidCon 2026, showcasing to creators how to build sustainable business around their content 
Company brings Amaze Commerce and The Food Channel to VidCon 2026, showcasing to creators how to build sustainable business around their content

PEPSI® GLOBAL LAUNCHES PEPSI ‘HOUSE OF TREATS’ A NEW AWAY FROM HOME EXPERIENTIAL BEVERAGE PLATFORM

DUBLIN, June 10, 2026 /PRNewswire/ -- Pepsi® Global has launched Pepsi "House of Treats", a new crafted beverages platform designed to deliver experience-first drinks...

PEPSI® GLOBAL LAUNCHES PEPSI ‘HOUSE OF TREATS’ A NEW AWAY FROM HOME EXPERIENTIAL BEVERAGE PLATFORM

DUBLIN, June 10, 2026 /PRNewswire/ -- Pepsi® Global has launched Pepsi "House of Treats", a new crafted beverages platform designed to deliver experience-first drinks...

Monthly disclosure on share capital and voting rights ERRATUM May 31, 2026


Issy-les-Moulineaux, June 10, 2026

Finnish bio-based materials project advances 100% cellulose-based film and coating technology as a scalable alternative to fossil-based packaging

A new cellulose-based material platform developed in Finland responds to tightening regulatory requirements and industry pressure to both replace and reduce plastic in packaging,...

NeuroRester Launches Wearable 2.0: An Ecosystem Designed to Move Beyond Tracking with Proprietary NAP™ Technology

CAMPBELL, Calif., June 8, 2026 /PRNewswire/ -- After a decade of consumers being overwhelmed with biometric data but lacking supportive ways to act on it,...

A&W ANNOUNCES MAJOR CANADIAN AIRPORT EXPANSION OF PRET A MANGER

New locations at major Canadian airports, including Vancouver International Airport, to begin opening this summer as Pret accelerates Canadian growthVANCOUVER, BC, June 9, 2026...

FDA approves Lilly’s EBGLYSS® (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis

EBGLYSS is now the only approved option that offers as few as six maintenance injections per year with no required topicals from the startINDIANAPOLIS,...

Maui Land & Pineapple Company, Inc. Appoints a Chief Investment Officer

KAPALUA, Hawai‘i, June 09, 2026 (GLOBE NEWSWIRE) -- Maui Land & Pineapple Company, Inc. (NYSE: MLP) today announced the appointment of Ryan Panopio as the Company’s Chief Investment Officer effective June 3, 2026.

The North West Company Inc. Announces First Quarter Earnings and a Quarterly Dividend

WINNIPEG, Manitoba, June 09, 2026 (GLOBE NEWSWIRE) -- (TSX: NWC): The North West Company Inc. (the "Company" or "North West") today reported its unaudited financial results for the first quarter ended April 30, 2026. It also announced that the Board of Directors has declared a quarterly dividend of $0.41 to shareholders of record on June 30, 2026, to be paid on July 15, 2026.

Canada launches mission to combat illegal, unreported and unregulated fishing in the North Pacific Ocean

OTTAWA, ON, June 9, 2026 /CNW/ - Illegal, unreported, and unregulated (IUU) fishing threatens national and international fish stocks and the broader ocean ecosystem....

Boylan Bottling Launches Freedom Cola: A Limited-Edition Craft Soda Celebrating 250 Years of American Independence

The 135-year-old cane sugar soda brand introduces a seasonal patriotic release — available online nationwide and across the New York metro area through Big...

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today announced that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to lasmecabtagene timgedleucel (lasme-cel), its CD22-targeting allogeneic CAR-T cell therapy product candidate, for the treatment of patients with relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-ALL).

Grocery Outlet Holding Corp. Announces Leadership Updates

Paul Miller Rejoins Grocery Outlet as Chief Purchasing and Merchandising Officer
Ian Ferry Promoted to Chief Financial Officer
Company Affirms Second Quarter and Fiscal 2026 Outlook

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFood

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers